The cyclic GMP-AMP synthase (cGAS)-stimulator interferon genes (STING) signaling pathway is pivotal in activating both innate and specific immunity within anti-tumor immunotherapy [16, 17]. This evidence concerns the gene STING1 and neoplasm.